Assenagon Asset Management S.A. lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,597 shares of the medical equipment provider’s stock after selling 5,916 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Intuitive Surgical were worth $4,899,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Elite Wealth Management Inc. lifted its position in Intuitive Surgical by 0.3% during the second quarter. Elite Wealth Management Inc. now owns 5,128 shares of the medical equipment provider’s stock worth $2,922,000 after buying an additional 15 shares in the last quarter. Country Club Trust Company n.a. grew its stake in shares of Intuitive Surgical by 4.3% in the second quarter. Country Club Trust Company n.a. now owns 486 shares of the medical equipment provider’s stock valued at $269,000 after buying an additional 20 shares in the last quarter. BOK Financial Private Wealth Inc. grew its stake in shares of Intuitive Surgical by 4.8% in the first quarter. BOK Financial Private Wealth Inc. now owns 457 shares of the medical equipment provider’s stock valued at $226,000 after buying an additional 21 shares in the last quarter. Ieq Capital LLC grew its stake in shares of Intuitive Surgical by 3.6% in the first quarter. Ieq Capital LLC now owns 630 shares of the medical equipment provider’s stock valued at $312,000 after buying an additional 22 shares in the last quarter. Finally, First Allied Advisory Services Inc. grew its stake in shares of Intuitive Surgical by 1.1% in the first quarter. First Allied Advisory Services Inc. now owns 2,074 shares of the medical equipment provider’s stock valued at $1,027,000 after buying an additional 23 shares in the last quarter. Institutional investors and hedge funds own 87.24% of the company’s stock.
Intuitive Surgical stock opened at $686.55 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $360.50 and a fifty-two week high of $699.72. The company has a market capitalization of $79.23 billion, a P/E ratio of 72.19, a PEG ratio of 15.22 and a beta of 0.93. The stock has a 50-day simple moving average of $585.88 and a 200-day simple moving average of $551.14.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 21st. The medical equipment provider reported $1.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.59 by $0.52. Intuitive Surgical had a return on equity of 13.86% and a net margin of 26.07%. The business had revenue of $852.10 million during the quarter, compared to the consensus estimate of $675.15 million. During the same period in the previous year, the business earned $3.25 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.62 earnings per share for the current year.
ISRG has been the subject of a number of research reports. Bank of America reaffirmed a “buy” rating and issued a $650.00 price objective on shares of Intuitive Surgical in a research note on Thursday, April 9th. Morgan Stanley boosted their target price on Intuitive Surgical from $602.00 to $735.00 and gave the stock an “overweight” rating in a research note on Wednesday. Cfra cut Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, April 17th. Evercore ISI cut Intuitive Surgical from an “in-line” rating to an “underperform” rating in a research note on Sunday, April 19th. Finally, Wells Fargo & Co lifted their price target on Intuitive Surgical from $632.00 to $727.00 and gave the stock an “overweight” rating in a report on Wednesday. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $660.67.
In other Intuitive Surgical news, EVP David J. Rosa sold 17,950 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $553.49, for a total transaction of $9,935,145.50. Following the completion of the sale, the executive vice president now directly owns 37,269 shares of the company’s stock, valued at approximately $20,628,018.81. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Marshall Mohr sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $525.00, for a total value of $3,937,500.00. Following the sale, the chief financial officer now directly owns 17,672 shares of the company’s stock, valued at $9,277,800. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 32,775 shares of company stock valued at $18,181,874. 1.60% of the stock is owned by company insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.